Table 2.

Characteristics of prescribed statin drugs among new statin users

	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015
Number of new statin users	8205	8835	11 181	12 564	12 774	13 333	15 139	14 713	14 374	14 639	14 117	15 731	15 514
Monotherapy (%)	100	100	99	98	97	98	97	97	95	94	95	96	95
Atorvastatin	18	19	20	18	18	46	61	61	62	63	66	51	49
Fluvastatin	4	2	2	4	4	2	1	1	1	1	1	1	0
Lovastatin	30	18	12	6	4	2	1	1	1	0	0	0	0
Pitavastatin	0	0	1	7	9	7	4	4	4	4	6	5	5
Pravastatin	11	8	6	5	4	4	3	3	3	2	2	2	1
Rosuvastatin	0	2	7	9	8	7	7	9	8	8	8	33	36
Simvastatin	37	50	52	49	50	31	20	18	16	14	9	5	3
Combination	0	0	1	2	3	2	3	3	5	6	5	4	5
Intensity (%)
Low	43	25	17	11	9	6	5	5	5	5	5	3	3
Moderate	57	75	83	88	90	94	94	94	93	93	93	92	92
High	0	0	0	0	1	1	1	2	2	2	2	4	5
Institution (%)
Primary	63	61	59	59	58	58	56	56	56	57	56	58	58
Secondary	20	23	25	26	26	25	27	28	28	28	29	29	29
Tertiary	14	13	13	14	14	13	14	13	14	13	12	11	11
Others	3	2	2	2	3	3	4	3	3	2	2	2	2